Yes. The tremendous push being made into new frontiers of science is beginning to bear fruit. Earlier this year, for example, FDA approved the first anti-cancer medicine based on angiogenesis inhibition, which kills tumors by restricting their blood supply. It took three decades of research in this field before the first new medicine emerged. The number of truly novel drugs approved by FDA in 2003 was up 20 percent from the year before, and the number of investigational applications for novel therapies also increased.
Pharmaceutical researchers are on the verge of a new era in medicine that holds great promise for patients and our healthcare system. We can discover, if we make a sustained, substantial investment in research and development, and create a public policy environment that supports continued innovation.
Yes. The tremendous push being made into new frontiers of science
is beginning to bear fruit. Earlier this year, for example, FDA
approved the first anti-cancer medicine based on angiogenesis
inhibition, which kills tumors by restricting...
More
PhRMA answered:Yes. The tremendous push being made into new frontiers of science is beginning to bear fruit. Earlier this year, for example, FDA approved the first anti-cancer medicine based on angiogenesis inhibition, which kills tumors by restricting their blood supply. It took three decades of research in this field before the first new medicine emerged. The number of truly novel drugs approved by FDA in 2003 was up 20 percent from the year before, and the number of investigational applications for novel therapies also increased.
